Using targeted brain stimulation to help treat alcohol use disorder
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
This study is looking at how a special treatment called transcranial magnetic stimulation (TMS) might help people with alcohol use disorder by reducing their cravings when they see things that remind them of drinking, and you could be part of it!
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10863674 on NIH RePORTER |
What this research studies
This research investigates the use of transcranial magnetic stimulation (TMS) as a targeted treatment for individuals with alcohol use disorder (AUD). By applying electromagnetic pulses to specific areas of the brain, the study aims to reduce the brain's reactivity to alcohol cues, which is linked to relapse. The approach is based on previous findings that show a connection between brain activity and relapse rates in AUD patients. Participants may receive either real TMS or a placebo treatment in a controlled setting to assess the effectiveness of this intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol use disorder who are seeking treatment.
Not a fit: Patients who do not have alcohol use disorder or those who are not interested in participating in a clinical trial may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatments for individuals struggling with alcohol use disorder.
How similar studies have performed: Previous studies have shown promising results with TMS in reducing relapse rates in alcohol use disorder, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mccalley, Daniel — Stanford University
- Study coordinator: Mccalley, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.